AU770187B2 - Process for the fermentative production of L-amino Acids using coryneform bacteria - Google Patents
Process for the fermentative production of L-amino Acids using coryneform bacteria Download PDFInfo
- Publication number
- AU770187B2 AU770187B2 AU17600/00A AU1760000A AU770187B2 AU 770187 B2 AU770187 B2 AU 770187B2 AU 17600/00 A AU17600/00 A AU 17600/00A AU 1760000 A AU1760000 A AU 1760000A AU 770187 B2 AU770187 B2 AU 770187B2
- Authority
- AU
- Australia
- Prior art keywords
- bacteria
- amino acids
- process according
- glutamate dehydrogenase
- fermentation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y104/00—Oxidoreductases acting on the CH-NH2 group of donors (1.4)
- C12Y104/01—Oxidoreductases acting on the CH-NH2 group of donors (1.4) with NAD+ or NADP+ as acceptor (1.4.1)
- C12Y104/01002—Glutamate dehydrogenase (1.4.1.2)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/0004—Oxidoreductases (1.)
- C12N9/0012—Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.6, 1.7)
- C12N9/0014—Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.6, 1.7) acting on the CH-NH2 group of donors (1.4)
- C12N9/0016—Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.6, 1.7) acting on the CH-NH2 group of donors (1.4) with NAD or NADP as acceptor (1.4.1)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P13/00—Preparation of nitrogen-containing organic compounds
- C12P13/04—Alpha- or beta- amino acids
- C12P13/06—Alanine; Leucine; Isoleucine; Serine; Homoserine
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P13/00—Preparation of nitrogen-containing organic compounds
- C12P13/04—Alpha- or beta- amino acids
- C12P13/08—Lysine; Diaminopimelic acid; Threonine; Valine
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P13/00—Preparation of nitrogen-containing organic compounds
- C12P13/04—Alpha- or beta- amino acids
- C12P13/22—Tryptophan; Tyrosine; Phenylalanine; 3,4-Dihydroxyphenylalanine
- C12P13/227—Tryptophan
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P13/00—Preparation of nitrogen-containing organic compounds
- C12P13/04—Alpha- or beta- amino acids
- C12P13/24—Proline; Hydroxyproline; Histidine
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- General Health & Medical Sciences (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Enzymes And Modification Thereof (AREA)
Abstract
Preparation of L-amino acids comprises fermentation of coryneform bacteria in which the nucleotide sequence encoding glutamate dehydrogenase (GDH) is amplified, especially over-expressed.
Description
S&F Ref. 494670
AUSTRALIA
PATENTS ACT 1990 COMPLETE SPECIFICATION FOR A STANDARD PATENT
ORIGINAL
Name and Address of Applicants: Degussa Hu Atingiebcaf Germany 0
S.
*0 Forschungszentrum Julich GmbH D-52425 Julich Germany Actual Inventor(s): Address for Service: Invention Title: Achim Marx, Bettina Mockel, Walter Pfefferle, Hermann Sahm, Albert De Graaf and Lothar Eggeling Spruson Ferguson St Martins Tower 31 Market Street Sydney NSW 2000 Process for the Fermentative Production of L-amino Acids using Coryneform. Bacteria The following statement is a full description of this invention, including the best method of performing it known to me/us:- IPAUs tra lia Documents r c i e n 1 8 t-k6
(D
Batch No: E 5845c 980182 BT 1 Process for the fermentative production of L-amino acids using coryneform bacteria The present invention provides a process for the fermentative production of L-amino acids using coryneform bacteria, in which the glutamate dehydrogenase gene is amplified.
Prior art L-Amino acids are used in animal nutrition, human medicine and the pharmaceuticals industry.
L-Amino acids are produced by fermentation using strains of coryneform bacteria which produce L-amino acids, in particular using Corynebacterium glutamicum. Due to the significance of this group of products, efforts are constantly being made to improve the production process.
15 Improvements to the process may relate to measures concerning fermentation technology, for example stirring and oxygen supply, or to the composition of the nutrient media, such as for example sugar concentration during fermentation, or to working up of the product by, for 20 example, ion exchange chromatography, or to the intrinsic performance characteristics of the microorganism itself.
The performance characteristics of these microorganisms are improved using methods of mutagenesis, selection and mutant selection. In this manner, strains are obtained which are resistant to antimetabolites, such as for example the lysine analogue S-(2-aminoethyl)cysteine, or are auxotrophic for regulatorily significant amino acids and produce L-amino acids.
For some years, methods of recombinant DNA technology have also been used to improve strains of Corynebacterium glutamicum which produce L-amino acids by amplifying individual biosynthesis genes and investigating the effect on L-amino acid production. Review articles on this subject may be found inter alia in Kinoshita ("Glutamic Acid Bacteria", in: Biology of Industrial Microorganisms, Demain and Solomon Benjamin Cummings, London, UK, 1985, 115-142), Hilliger (BioTec 2, 40-44 (1991)), Jetten and Sinskey (Critical Reviews in Biotechnology 15, 73-103 (1995)) and Sahm et al. (Annals of the New York Academy of Science 782, 25-39 (1996)).
The enzyme glutamate dehydrogenase catalyses the reductive amination of aketoglutaric acid to yield glutamic acid. French published patent application 2 575 492 describes a DNA fragment from Corynebacterium melassecola 801 which bears a glutamate dehydrogenase gene. It is possibly used therein to increase glutamic acid 0o production in the fermentation of Corynebacterium melassecola. The nucleotide sequence of the glutamate dehydrogenase gene of Corynebacteriurn glutamicum ATCC13032 has been described by B6rmann et al. (Molecular Microbiology 6, 317-326 (1992)). The nucleotide sequence of the glutamate dehydrogenase gene of Peptostreptococcus asaccharolyticus is stated in Snedecor et al. (Journal of Bacteriology 193, 6162-6167 (1991)).
Object of the Invention The inventors set themselves the object of providing novel measures for the improved fermentative production of other L-amino acids.
Summary of the Invention According to the invention, there is provided a process for the production of one or more L-amino acids selected from L-threonine, L-isoleucine, L-valine, or salts thereof by fermentation of coryneform bacteria, characterised in that bacteria are used in which the nucleotide sequence coding for glutamate dehydrogenase is amplified, and isolating said one or more amino acids from the fermentation medium. L-Amino acids selected from Lthreonine, L-isoleucine, L-valine, or salts thereof, when produced by the process of the invention, are also provided.
Description of the Invention L-Amino acids are used in animal nutrition, human medicine and the pharmaceuticals industry. There is accordingly general interest in providing improved processes for the production of L-amino acids.
When L-amino acids are mentioned below, they are taken to mean the proteinforming amino acids L-lysine, L-threonine, L-isoleucine, L-valine, L-proline, Ltryptophan and A05889 if i;i; i r I 980182 BT 3 optionally the salts thereof and also L-homoserine, in particular L-lysine, L-threonine and L-tryptophan.
The present invention provides a process for the fermentative production of L-amino acids using coryneform bacteria, which in particular already produce the corresponding L-amino acids and in which the nucleotide sequence coding for the enzyme glutamate dehydrogenase is amplified, in particular overexpressed.
Preferred embodiments are stated in the claims.
In this connection, the term "amplification" describes the increase in the intracellular activity of one or more enzymes in a microorganism, which enzymes are coded by the corresponding DNA, for example by increasing the copy number of the gene or genes, by using a strong promoter or 15 a gene which codes for a corresponding enzyme having elevated activity and optionally by combining these measures.
The microorganisms provided by the present invention are capable of producing L-amino acids from glucose, sucrose, lactose, fructose, maltose, molasses, starch, cellulose or from glycerol and ethanol. The microorganisms may comprise representatives of the coryneform bacteria in particular of the genus Corynebacterium. Within the genus Corynebacterium, Corynebacterium glutamicum may in 25 particular be mentioned, which is known in specialist circles for its ability to produce L-amino acids.
Suitable strains of the genus Corynebacterium, in particular of the species Corynebacterium glutamicum, are the known wild type strains Corynebacterium glutamicum ATCC13032 Corynebacterium acetoglutamicum ATCC15806 Corynebacterium acetoacidophilum ATCC13870 Corynebacterium thermoaminogenes FERM BP-1539 Brevibacterium flavum ATCC14067 980182 BT 4 Brevibacteriurn lactofer-men turn ATCC13869 and Brevibacteriurn divarica turn ATCC14020 and mutants or strains produced therefrom, such as for example the L-lysine producing strains Corynebacteriun glutamicum FERM-P 1709 Brevibacteriun flavun FERM-P 1708 and Brevibacteriun lactofernenturn FERM-P 1712, or the L-threonine producing strains Corynebacterium glutanicun FERN-P 5835 Brevibacteriun flavun FERN-P 4164 and Brevibacteriun lactofernentun FERN-P 4180, or the L-isoleucine producing strains Corynebacteriurn glutanicun FERM-P 756 Brevibacteriurn flavurn FERM-P 759 and Brevibacteriun lactofernentun FERN-P 4192 or the L-valine producing strains Brevibacteriun flavun FERM-P 512 and Brevibacteriurn lactoferrnentun FERM-P 1845, and the L-tryptophan producing strains Corynebacteriurn glutarnicum FERM-BP 478 Brevibacterium flavum FERM-BP 475 and Brevibacteriurn lactofernenturn FERM-P 7127.
The inventors discovered that, after overexpression of L-glutamate dehydrogenase, coryneform bacteria produce 980182 BT L-amino acids in an improved manner, wherein L-glutamic acid is not claimed here.
The glutamate dehydrogenase gene of C. glutamicum described by B6rmann et al. (Molecular Microbiology 6, 317-326 (1992)) may be used according to the invention. The glutamate dehydrogenase gene from other microorganisms, such as for example that from Peptostreptococcus asaccharolyticus, which has been described by Snedecor et al. (Journal of Bacteriology 173, 6162-6167 (1991)), is also suitable. Alleles of the stated genes arising from the degeneracy of the genetic code or from functionally neutral sense mutations may also be used.
Overexpression may be achieved by increasing the copy number of the corresponding genes, or the promoter and 15 regulation region located upstream from the structural gene may be mutated. Expression cassettes incorporated upstream from the structural gene act in the same manner. It is additionally possible to increase expression during fermentative L-amino acid production by means of inducible 20 promoters. Expression is also improved by measures to extend the lifetime of the mRNA. Enzyme activity is moreover amplified by preventing degradation of the enzyme Se. protein. The genes or gene constructs may either be present in plasmids in a variable copy number or be integrated in 25 the chromosome and amplified. Alternatively, overexpression of the genes concerned may also be achieved by modifying the composition of the nutrient media and culture conditions.
The person skilled in the art will find guidance in this connection inter alia in Martin et al. (Bio/Technology 137-146 (1987)), in Guerrero et al. (Gene 138, 35-41 (1994)), Tsuchiya and Morinaga (Bio/Technology 6, 428-430 (1988)), in Eikmanns et al. (Gene 102, 93-98 (1991)), in European patent EPS 0 472 869, in US patent 4,601,893, in Schwarzer and Pfhler (Bio/Technology 9, 84-87 (1991), in Reinscheid et al. (Applied and Environmental Microbiology 126-132 (1994)), in LaBarre et al. (Journal of Bacteriology 175, 1001-1007 (1993)), in patent application WO 96/15246, in Jensen and Hammer (Biotechnology and Bioengineering 58, 191-195 (1998)), in Makrides (Microbiological Reviews 60:512-538 (1996)) and in known textbooks of genetics and molecular biology.
Examples of plasmids by means of which glutamate dehydrogenase may be overexpressed are pEK1.9gdh-1 and pEKExpgdh, which are present in strains ATCC13032/pEK1.9gdh-l and DH5c/pEKExpgdh. Plasmid pEK1.9gdh-l is a shuttle vector, which contains the NADPdependent glutamate dehydrogenase gene of C. glutamicum.
Plasmid pEKExpgdh is a shuttle vector, which contains the NADH-dependent glutamate dehydrogenase [gene] of Peptostreptococcus asaccharolyticus.
It may additionally be advantageous for the production of the corresponding L-amino acids to overexpress one or more enzymes of the particular amino acid biosynthesis pathway as well as glutamate dehydrogenase. Thus, for example the dapA gene which codes for dihydrodipicolinate synthase may additionally be overexpressed in order to improve L-lysine producing coryneform bacteria (EP-B 0197335), the gene which codes for acetohydroxy acid synthase may additionally be overexpressed in order to improve Lvaline producing coryneform bacteria (EP-B 0356739), the gene which codes for anthranilic acid phosphoribosyl transferase may additionally be overexpressed in order to improve L-tryptophan producing coryneform bacteria (EP-B 30 0124048) the gene which codes for homoserine dehydrogenase may additionally be overexpressed in order to improve coryneform bacteria which produce L-homoserine or L-threonine or L-isoleucine (EP-A 0131171) I' i i 980182 BT 7 It may furthermore be advantageous for the production of the corresponding L-amino acid to switch off unwanted secondary reactions in addition to overexpressing glutamate dehydrogenase (Nakayama: "Breeding of Amino Acid Producing Micro-organisms", in: Overproduction of Microbial Products, Krumphanzl, Sikyta, Vanek Academic Press, London, UK, 1982).
For the purposes of L-amino acid production, the microorganisms according to the invention may be cultivated continuously or discontinuously using the batch process or the fed batch process or repeated fed batch process. A summary of known cultivation methods is given in the textbook by Chmiel (Bioprozesstechnik 1. Einfihrung in die Bioverfahrenstechnik (Gustav Fischer Verlag, Stuttgart, 15 1991)) or in the textbook by Storhas (Bioreaktoren und periphere Einrichtungen (Vieweg Verlag, Braunschweig/Wiesbaden, 1994)).
The culture medium to be used must adequately satisfy the requirements of the particular strains. Culture media for 20 various microorganisms are described in "Manual of Methods for General Bacteriology" from American Society for Bacteriology (Washington USA, 1981). Carbon sources which may be used include sugars and carbohydrates, such as for example glucose, sucrose, lactose, fructose, maltose, 25 molasses, starch and cellulose, oils and fats, such as for example soya oil, sunflower oil, peanut oil and coconut oil, fatty acids, such as for example palmitic acid, stearic acid and linoleic acid, alcohols, such as for example glycerol and ethanol, and organic acids, such as for example acetic acid. These substances may be used individually or as a mixture. Nitrogen sources which may be used comprise organic compounds containing nitrogen, such as peptone, yeast extract, meat extract, malt extract, corn steep liquor, soya flour and urea or inorganic compounds, such as ammonium sulfate, ammonium chloride, ammonium phosphate, ammonium carbonate and ammonium nitrate. The 980182 BT 8 nitrogen sources may be used individually or as a mixture.
Phosphorus sources which may be used are potassium dihydrogen phosphate or dipotassium hydrogen phosphate or the corresponding salts containing sodium. The culture medium must furthermore contain metal salts, such as for example magnesium sulfate or iron sulfate, which are necessary for growth. Finally, essential growth-promoting substances such as amino acids and vitamins may also be used in addition to the above-stated substances. Suitable precursors may furthermore be added to the culture medium.
The stated feed substances may be added to the culture as a single batch or be fed appropriately during cultivation.
Basic compounds, such as sodium hydroxide, potassium *hydroxide, ammonia, or acidic compounds, such as phosphoric 15 acid or sulfuric acid, are used appropriately to control the pH of the culture. Antifoaming agents, such as for example fatty acid polyglycol esters, may be used to control foaming. Suitable selectively acting substances, such as for example antibiotics, may be added to the medium 20 in order to maintain plasmid stability. Oxygen or gas mixtures containing oxygen, such as for example air, are introduced into the culture in order to maintain aerobic conditions. The temperature of the culture is normally from 20 0 C to 45 0 C and preferably from 25 0 C to 40 0 C. The culture is continued until a maximum quantity of the desired L-amino acid has been formed. This objective is normally achieved within 10 hours to 160 hours.
L-Amino acids may be analysed automatically using anion exchange chromatography with subsequent ninhydrin derivatisation, as described by Spackman et al. (Analytical Chemistry, 30, 1190 (1958)).
The following microorganisms have been deposited with Deutschen Sammlung far Mikrorganismen und Zellkulturen (DSMZ, Braunschweig, Germany) in accordance with the Budapest Treaty: 9 Cotynebacterium glutamicum strain ATCC 13032/pEK1.9gdh-1 as DSM 12614 on 8 January 1999.
Escherichia co/i K12 strain DH5a/pEKExpgdh as DSM 12613 on 8 January 1999.
.00.
00* 0 0 0 0 0 00 0 0 C08 102 980182 BT Examples The present invention is illustrated in greater detail by the following practical examples.
To this end, testing was performed with amino acid producing strains, in which the superiority of the claimed process is demonstrated: a) the L-lysine producing strain Corynebacterium glutamicum DSM5715, (EP-B- 0435 132) and b) the L-threonine and L-isoleucine producing strain Brevibacterium flavum DSM5399 (EP-B- 0385 940) and c) the L-valine producing, isoleucine-requiring strain ATCC13032AilvA, which has been deposited as DSM12455 with Deutschen Sammlung fir Mikroorganismen und Zellkulturen in Braunschweig (Germany) in accordance 15 with the Budapest Treaty.
Example 1 Production of L-amino acid producers with amplified glutamate dehydrogenase 20 Plasmid pEK1.9gdh-l corresponds to the plasmid pEK1.9gdh *I described by B6rmann et al. (Molecular Microbiology 6, 317- 326 (1992)). It was isolated from ATCC13032/pEK1.9gdh-1.
-The known plasmid pEKExpgdh (Marx et al., Metabolic Engineering 1, 35-48 (1999)), which bears the glutamate dehydrogenase gene of Peptostreptococcus asaccharolyticus (Snedecor et al., Journal of Bacteriology 173, 6162-6167 (1991)) was isolated in the same manner from E. coli strain Strains DSM5715, DSM5399 and ATCC13032AilvA were transformed with plasmid pEK1.9gdh-l as described by Liebl et al. (FEMS Microbiology Letters 65, 299-304 (1989)). The transformants were selected on brain/heart agar from Merck (Darmstadt, Germany) which had been supplemented with mg/l of kanamycin. In this manner, strains 980182 BT 11 DSM5715/pEK1.9gdh-1, DSM5399/pEK1.9gdh-1 and ATCC13032AilvA/pEK1.9gdh-1 were obtained. Strain DSM5715 was transformed in the same manner with plasmid pEKExpgdh and strain DSM5715/pEKExpgdh obtained.
Example 2 Production of L-lysine Strain DSM5715/pEK1.9gdh-1 was precultivated in complex medium 2TY consisting of 16 g/l of tryptone, 10 g/l of yeast extract and 5 g/l of NaC1. To this end, 60 ml of medium 2TY, contained in a 500 ml Erlenmeyer flask with 2 flow spoilers, were inoculated with an inoculating loop of the strain and the culture incubated for 12 hours at 150 rpm and 30 0
C.
In order to inoculate 60 ml of production medium, contained 15 in a 500 ml Erlenmeyer flask with 2 flow spoilers, the preculture was centrifuged for 10 minutes at 5000 rpm in a Sepatech Minifuge RF (Heraeus, Hanau, Germany) centrifuge.
The supernatant was discarded and the pellet resuspended in 1 ml of production medium. An aliquot of this cell suspension was added to the production medium, such that an OD600 of approx. 2.0 was obtained. The production medium used was medium CGXII with a pH of 7.0 (Table 1) described by Keilhauer et al. (Journal of Bacteriology 175, 5595-5603 (1993)) supplemented with 20 g/l of glucose, 350 mg/1 of 25 leucine and 50 mg/l of kanamycin monosulfate. The cultures were incubated for 72 hours at 30 0 C and 150 rpm.
980182 BT 12 Table 1 goo* 0 S.
0000 .00.
0 00 Component Concentration per litre
(NH
4 2 1S0 4 20 g Urea 5g9
KH
2
PO
4 1 g
K
2
HPO
4 1 g MgSO, 7H 2 0 0.25g 3-Morpholinopropane- 42 g sulfonic acid FeSO 4 7H 2 0 10 mg MnSO 4
H
2 0 10 mg ZnSO 4 7H 2 0 1 mg CUS0 4 0.2 mg NiC1 2 6H 2 0 0.02 mg CaCl 2 10 mg Protocatechuic acid 0.03 mg Biotin 200 /ig optical density (GD) (Biochrom Novaspec 4049, LKB Instrument GmbH, Grafelfing, Germany) was then determined at a measuring wavelength of 600 nm, as was the concentration of L-lysine formed using an amino acid analyser from Eppendorf-Bio'rronik (Hamburg, Germany) by ion 980182 BT 13 exchange chromatography and post-column reaction with ninhydrin detection. Table 2 shows the result of the test.
Table 2 Strain OD L-lysine g/1 DSM5715 16.5 DSM5715/pEK1.9gdh-1 19.4 6.2 *00 Example 3 Production of L-threonine and L-isoleucine Strain DSM5399/pEK1.9gdh-1 was precultivated in complete medium CgIII (Kase Nakayama, Agricultural and Biological 10 Chemistry 36 1611- 1621 (1972)) with 50Jmg/ml of 0kanamycin. To this end, 10 ml of medium CgIII, contained in a 100 ml Erlenmeyer flask with 4 flow spoilers, were inoculated with an inoculating loop of the strain and the culture incubated for 16 hours at 240 rpm and 30 0
C.
15 In order to inoculate 10 ml of production medium, contained in a 100ml Erlenmeyer flask with 4 flow spoilers, the OD (660 nm) of the preculture was determined. The main culture was inoculated to an OD of 0.1. The production medium used was the medium CgXII described by Keilhauer et al. (Journal of Bacteriology 1993, 175: 5595 5603). The composition of the medium is shown in Example 2. 4% of glucose and 50 mg/l of kanamycin sulfate were added. The cells were incubated for 48 hours at 33 0 C, 250 rpm and 80% atmospheric humidity.
Optical density at 660 nm was then determined, as was the concentration of the L-threonine and L-isoleucine formed as stated in Example 2. Table 3 shows the result of the test.
980182 BT 14 Table 3 Strain OD L-threonine Lg/1 isoleucine DSM5399 10.5 1.77 1.05 DSM5399/pEKl,9gdh-1 11.0 2.26 1.44 Example 4 Production of L-valine Strain ATCC13032AilvA/pEKl.9gdh-l was precultivated in complete medium CgIII (Kase Nakayama, Agricultural and *Biological Chemistry 36 1611- 1621 (1972)) with 50 pg/ml of kanamycin. To this end, 50 ml of medium CgIII, contained in a 500 ml Erlenmeyer flask with 4 flow spoilers, were inoculated with an inoculating loop of the strain and the culture incubated for 16 hours at 140 rpm and 30 0
C.
In order to inoculate 60 ml of production medium, contained in a 500 ml Erlenmeyer flask with 4 flow spoilers, the OD (660 nm) of the preculture was determined. The main culture 15 was centrifuged and the supernatant discarded. The pellet was resuspended in 5 ml of production medium and the main culture inoculated to an OD of 0.3. The production medium used was medium CgXII (Keilhauer et al., Journal of Bacteriology 1993 175: 5595 5603) as described in Example 3 (with 4% glucose). The cells were incubated for 48 hours at 30 0 C, 150 rpm.
Optical density at 660 nm was then determined, as was the concentration of L-valine formed as described as stated in Example 2. Table 4 shows the result of the test.
980182 BT Table 4 Strain OD L-valine g/1 ATCC13032AilvA 18.5 0.29 ATCC13032AilvA /pEK1.9gdh-l 17.6 0.45 Example Production of L-lysine, L-valine and L-alanine Strain DSM5715/pEKExpgdh was precultivated in complex medium 2TY consisting of 16 g/l of tryptone, 10 g/1 of yeast extract and 5 g/l of NaC1. To this end, 60 ml of medium 2TY, contained in a 500 ml Erlenmeyer flask with 2 flow spoilers, were inoculated with an inoculating loop of the strain and the culture incubated for 12 hours at 150 rpm and 30 0
C.
In order to inoculate 60 ml of production medium, contained in a 500 ml Erlenmeyer flask with 2 flow spoilers, the preculture was centrifuged for 10 minutes at 5000 rpm in a 15 Sepatech Minifuge RF (Heraeus, Hanau, Germany) centrifuge.
The supernatant was discarded and the pellet resuspended in 1 ml of production medium. An aliquot of this cell suspension was added to the production medium such that an OD600 of approx. 0.4 was obtained. The production medium used was medium CGC (table 5) described by Schrumpf et al.
(Journal of Bacteriology 173, 4510-4516 (1991)), supplemented with 25 g/l of glucose, 350 mg/l of leucine, 42 g/l of 3 -morpholinopropanesulfonic acid and 50 mg/l of kanamycin monosulfate at pH 7. The cultures were incubated for 30 hours at 30 0 C and 150 rpm.
980182 BT 16 Table Component Concentration per litre
(NH
4 2
SO
4 5 g Urea 5 g
KH
2
PO
4 0.5 g
K
2
HPO
4 0.5 g MgSO, 7H 2 0 0.25 g FeSO 4 7H 2 0 10 mg MnSO 4
H
2 0 10 mg ZnSO 4 7H 2 0 1 mg CuS04 0.2 mg NiCl2 6H 2 0 0.02 mg CaCl 2 2H 2 0 10 mg Biotin 200 ig Optical density (OD) Biochrom Novaspec 4049, LKB Instrument GmbH, Grafelfing, Germany) was then determined at a measuring wavelength of 600 nm, as was the concentration of L-alanine, L-lysine and L-valine formed using an amino acid analyser from Eppendorf-BioTronik (Hamburg, Germany) by ion exchange chromatography and postcolumn reaction with ninhydrin detection. Table 6 shows the result of the test.
980182 BT 17 Table 6 Strain OD L- L-lysine L-valine Alanine 9/l g/l1 DSM5715 29.4 Traces 1.6 0.1 DSM5715/pEKExpgdh 19.4 0.6 2.1 0.6
Claims (12)
1. Process for the production of one or more L-amino acids selected from L- threonine, L-isoleucine, L-valine, or salts thereof by fermentation of coryneform bacteria, characterised in that bacteria are used in which the nucleotide sequence coding for glutamate dehydrogenase is amplified, and isolating said one or more amino acids from the fermentation medium.
2. Process according to claim 1, characterised in that the nucleotide sequence coding for glutamate dehydrogenase is overexpressed.
3. Process according to claim 1 or claim 2, characterised in that the glutamate dehydrogenase produced in the bacteria used is NADP dependent.
4. Process according to claim 1 or claim 2, characterised in that bacteria are used in which the remaining genes in the metabolic pathway for the formation of the desired L- amino acids are additionally amplified.
Process according to claim 1 or claim 2, characterised in that bacteria are used in which the metabolic pathways which reduce the formation of the desired L-amino acid(s) are at least partially switched off.
6. Process according to any one of the preceding claims, characterised in that a strain transformed with a plasmid vector is used and the plasmid vector bears the nucleotide sequence coding for glutamate dehydrogenase.
7. Process according to claim 6, characterised in that a bacterium transformed with the plasmid vector pEK1. 9gdh-1, deposited in Corynebacterium glutamicum under number DSM 12614, is used. o
8. Process according to claim 6, characterised in that, bacteria transformed with the plasmid vector pEKExpgdh, deposited in E. coli under the number DSM 12613, are 25 used.
Process for the fermentative production of L-amino acids according to any one of the preceding claims, characterised in that the following steps are performed: a) fermentation of the bacteria producing L-amino acid(s), in which at least the glutamate dehydrogenase gene is amplified, b) accumulation of the desired L-amino acid(s) in the 30 medium or in the cells of the bacteria and c) isolation of the L-amino acid(s). I
10. Process according to any one of the preceding claims, characterised in that coryneform bacteria producing one or more of the amino acids L-threonine, L-isoleucine, L-valine, L-tryptophan and L-homoserine are used.
11. Process for the production of one or more L-amino acids selected from L- threonine, L-isoleucine, L-valine, or salts thereof by fermentation of coryneform bacteria, C08102 1~ I 19 said process being substantially as hereinbefore described with reference to any one of the examples.
12. L-amnino acids selected from L-threonine, L-isoleucine, L-valine, or salts thereof produced by fermentation of coryneform. bacteria in accordance with the process of any one of the preceding claims. Dated 1 December 2003 DEGUSSA-HUjLs AKTIENGESELLSCHAFT FORSCHUNGSZENTRUM JLICH GimriH Patent Attorneys for the Applicant/Nominated Person SPRUSON FERGUSON 0000 *0 *0 0 0 4 0* 0 000 0 0 *0 6 0000 0*0*0 .000 0: *0004 C08102
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19907347A DE19907347A1 (en) | 1999-02-20 | 1999-02-20 | Preparation of L-amino acids, e.g. L-lysine, L-threonine or L-isoleucine, useful in animal nutrition and pharmaceuticals, by fermentation of coryneform bacteria |
DE199073473 | 1999-02-20 | ||
US09/324940 | 1999-06-03 | ||
US09/324,940 US6355454B1 (en) | 1999-02-20 | 1999-06-03 | Process for the fermentative production of L-amino acids using coryneform bacteria |
Publications (2)
Publication Number | Publication Date |
---|---|
AU1760000A AU1760000A (en) | 2000-08-24 |
AU770187B2 true AU770187B2 (en) | 2004-02-12 |
Family
ID=26051968
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU17600/00A Ceased AU770187B2 (en) | 1999-02-20 | 2000-02-18 | Process for the fermentative production of L-amino Acids using coryneform bacteria |
Country Status (12)
Country | Link |
---|---|
EP (1) | EP1029919B1 (en) |
JP (1) | JP2000236893A (en) |
CN (1) | CN1222622C (en) |
AT (1) | ATE263246T1 (en) |
AU (1) | AU770187B2 (en) |
BR (1) | BRPI0000897B1 (en) |
CA (1) | CA2299105A1 (en) |
ES (1) | ES2218009T3 (en) |
HU (1) | HUP0000747A2 (en) |
ID (1) | ID24801A (en) |
RU (1) | RU2247778C2 (en) |
SK (1) | SK1942000A3 (en) |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP3965821B2 (en) * | 1999-03-09 | 2007-08-29 | 味の素株式会社 | Method for producing L-lysine |
US6939692B2 (en) | 2000-09-12 | 2005-09-06 | Degussa Ag | Nucleotide sequences coding for the pknB gene |
AU2001282132A1 (en) * | 2000-09-12 | 2002-03-26 | Degussa A.G. | Isolation and sequencing of the pknb gene of c. glutamicum |
DE10045496A1 (en) * | 2000-09-14 | 2002-03-28 | Degussa | New nucleotide sequences coding for the ptsi gene |
DE102004037572A1 (en) * | 2004-08-03 | 2006-02-23 | Degussa Ag | Process for the preparation of L-amino acids using strains of the family Enterobacteriaceae |
JP2010017081A (en) * | 2006-10-10 | 2010-01-28 | Ajinomoto Co Inc | Method for producing l-amino acid |
DE102006050489A1 (en) * | 2006-10-26 | 2008-04-30 | Evonik Degussa Gmbh | Coryneform bacterium mutant useful for amino acid production comprises a gene coding for a 2-methylcitrate dehydratase polypeptide with an amino acid other than proline at position 272 |
DE102006054202A1 (en) * | 2006-11-17 | 2008-05-21 | Evonik Degussa Gmbh | Alleles of the oxyR gene from coryneform bacteria |
CN101565723B (en) * | 2009-05-25 | 2011-06-01 | 河南孟成生物药业股份有限公司 | Fermentation production technique of L-tryptophan |
CN102653736A (en) * | 2012-04-12 | 2012-09-05 | 大连大学 | Fermenting production method of glutamate dehydrogenase by microorganisms |
CN103184247A (en) * | 2013-04-08 | 2013-07-03 | 绍兴市安杰生物科技有限公司 | Method for co-producing L-lactic acid with L-lysine |
PL2811028T3 (en) | 2013-06-03 | 2017-07-31 | Evonik Degussa Gmbh | Process for producing L-valine employing recombinant Corynebacteria comprising the propionate-inducible ilvBN operon |
KR101518860B1 (en) * | 2013-10-11 | 2015-05-12 | 씨제이제일제당 (주) | Method for producing L-amino acid |
RU2697005C2 (en) * | 2013-10-11 | 2019-08-08 | СиДжей ЧЕИЛДЗЕДАНГ КОРП. | Method of producing l-amino acids |
CN105505894A (en) * | 2014-09-24 | 2016-04-20 | 中国科学院天津工业生物技术研究所 | Aspartokinase/homoserine dehydrogenase mutant and application thereof |
CN105506014B (en) * | 2015-12-23 | 2019-02-12 | 湖南宝利士生物技术有限公司 | The biological synthesis method of high optical voidness L- homoserine and its derivative |
KR102112240B1 (en) * | 2018-09-28 | 2020-05-18 | 씨제이제일제당 주식회사 | A microorganism producing L-amino acids with enhanced alpha-glucosidase activity and a method for producing L-amino acids using the same |
CN109337854B (en) * | 2018-11-19 | 2020-11-03 | 南京工业大学 | Corynebacterium glutamicum capable of knocking out extracellular nuclease ExeR and construction method and application thereof |
CN111197014B (en) * | 2020-04-01 | 2022-11-08 | 宜昌三峡普诺丁生物制药有限公司 | Corynebacterium glutamicum mutant strain and application thereof |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2575492A1 (en) * | 1984-12-27 | 1986-07-04 | Asahi Chemical Ind | DNA fragment containing a gene encoding glutamate dehydrogenase, recombinant DNA containing it, and a recombinant microorganism containing the recombinant DNA |
AU2730399A (en) * | 1998-03-11 | 1999-09-27 | Valtion Teknillinen Tutkimuskeskus | Transformed microorganisms with improved properties |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB2223754B (en) * | 1988-09-12 | 1992-07-22 | Degussa | Dna encoding phosphoenolpyruvate carboxylase |
DE3943117A1 (en) * | 1989-12-27 | 1991-07-04 | Forschungszentrum Juelich Gmbh | METHOD FOR THE FERMENTATIVE PRODUCTION OF AMINO ACID, IN PARTICULAR L-LYSINE, THEREFORE SUITABLE MICROORGANISMS AND RECOMBINANT DNA |
-
2000
- 2000-02-08 ES ES00102601T patent/ES2218009T3/en not_active Expired - Lifetime
- 2000-02-08 EP EP00102601A patent/EP1029919B1/en not_active Expired - Lifetime
- 2000-02-08 AT AT00102601T patent/ATE263246T1/en not_active IP Right Cessation
- 2000-02-14 SK SK194-2000A patent/SK1942000A3/en unknown
- 2000-02-17 JP JP2000040048A patent/JP2000236893A/en active Pending
- 2000-02-18 HU HU0000747A patent/HUP0000747A2/en unknown
- 2000-02-18 CA CA002299105A patent/CA2299105A1/en not_active Abandoned
- 2000-02-18 AU AU17600/00A patent/AU770187B2/en not_active Ceased
- 2000-02-18 CN CNB00102728XA patent/CN1222622C/en not_active Expired - Lifetime
- 2000-02-18 ID IDP20000125A patent/ID24801A/en unknown
- 2000-02-18 RU RU2000103965/13A patent/RU2247778C2/en not_active IP Right Cessation
- 2000-02-21 BR BRPI0000897A patent/BRPI0000897B1/en active IP Right Grant
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2575492A1 (en) * | 1984-12-27 | 1986-07-04 | Asahi Chemical Ind | DNA fragment containing a gene encoding glutamate dehydrogenase, recombinant DNA containing it, and a recombinant microorganism containing the recombinant DNA |
AU2730399A (en) * | 1998-03-11 | 1999-09-27 | Valtion Teknillinen Tutkimuskeskus | Transformed microorganisms with improved properties |
Non-Patent Citations (1)
Title |
---|
MARX, A. ET AL., (1999) METABOLIC ENGINEERING VOL 1: 35-48 * |
Also Published As
Publication number | Publication date |
---|---|
EP1029919A2 (en) | 2000-08-23 |
JP2000236893A (en) | 2000-09-05 |
HUP0000747A2 (en) | 2002-09-28 |
ID24801A (en) | 2000-08-24 |
HU0000747D0 (en) | 2000-04-28 |
ATE263246T1 (en) | 2004-04-15 |
EP1029919B1 (en) | 2004-03-31 |
ES2218009T3 (en) | 2004-11-16 |
CA2299105A1 (en) | 2000-08-20 |
AU1760000A (en) | 2000-08-24 |
RU2247778C2 (en) | 2005-03-10 |
EP1029919A3 (en) | 2001-11-07 |
BRPI0000897B1 (en) | 2016-11-22 |
CN1266905A (en) | 2000-09-20 |
CN1222622C (en) | 2005-10-12 |
SK1942000A3 (en) | 2000-09-12 |
BR0000897A (en) | 2001-05-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU770187B2 (en) | Process for the fermentative production of L-amino Acids using coryneform bacteria | |
US6355454B1 (en) | Process for the fermentative production of L-amino acids using coryneform bacteria | |
US20040253628A1 (en) | Alleles of the lysC gene from corynebacteria | |
US7144724B2 (en) | Process for the production of L-amino acids by fermentation using coryneform bacteria | |
US7759056B2 (en) | Nucleotide sequence encoding the dapC gene and process for the production of L-lysine | |
AU2236900A (en) | Process for the production of L-amino acids by fermentation using coryeform | |
US6379934B1 (en) | Process for the fermentative preparation of L-amino acids using coryneform bacteria | |
US20020028490A1 (en) | Process for the production of L-amino acids by fermentation using coryneform bacteria | |
US20030087400A1 (en) | Process for the fermentative production of L-lysine using coryneform bacteria | |
CN1305009A (en) | Method of prducing L-amine acid by fermentation with corynebacteria | |
US20030109014A1 (en) | Process for the fermentative preparation of L-amino acids with amplification of the tkt gene | |
MXPA00001638A (en) | Process for the fermentative production of l-amino acids using coryneform bacteria | |
US20020127662A1 (en) | Process for the fermentative preparation of L-glutamic acid using coryneform bacteria | |
EP1361278A2 (en) | Process for the production of amino acids using phosphoglucose isomerases from coryneform bacteria | |
MXPA00002332A (en) | Process for the fermentative preparation of l-amino acids using coryneform bacteria | |
MXPA00004870A (en) | Process for the fermentative preparation of l-amino acids using coryneform bacteria |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PC1 | Assignment before grant (sect. 113) |
Owner name: DEGUSSA AG, FORSCHUNGSZENTRUM JULICH GMBH Free format text: THE FORMER OWNER WAS: DEGUSSA-HULS AKTIENGESELLSCHAFT, FORSCHUNGSZENTRUM JULICH GMBH |
|
FGA | Letters patent sealed or granted (standard patent) |